solution peptides glp-3 retatrutide RETATRUTIDE | NEOPEPS

Side Effects & Safety Nausea most common (~33% at high doses), dose-dependent, typically improves over time GI effects vomiting, diarrhea, constipation, slowed gastric emptying (GLP-1 class effects) Heart rate changes transient increases observed in trials, peaked at 24 weeks then declined Injection site reactions mild redness or irritation Gallbladder risk rapid weight loss increases gallstone risk (common with any rapid weight loss method) No major safety signals in 48-week trial up to 12 mg weekly At community doses (1.5 mg/week), side effects are notably milder than high-dose trial groups Dosage Chart This dosage chart consolidates the doses reported in published Phase 2 trials and self-reported community protocols, expressed in milligrams (mg) and converted to units on a standard 100-unit / 1mL insulin syringe

Compounded medications are prescribed based on a licensed provider's medical judgment, following a consultation and review of the patient's medical history

Holst JJ, Madsbad S, Bojsen-Mller KN, et al

Works with or without GLP-1 medications

Many cannabinoids accumulate in fat, and for chronic users, they can take weeks or months to clear completely from the body

Willow asks you to upload a photo ID or share the last four digits of your social security number, which isnt super common at other clinics